Dyne Therapeutics, Inc. (DYN)
18.52
+0.31
(+1.70%)
USD |
NASDAQ |
Sep 14, 16:00
18.52
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Market Cap : 3.068B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 3.068B |
| September 11, 2026 | 3.017B |
| September 10, 2026 | 3.052B |
| September 09, 2026 | 3.179B |
| September 08, 2026 | 3.365B |
| September 04, 2026 | 4.022B |
| September 03, 2026 | 4.133B |
| September 02, 2026 | 4.165B |
| September 01, 2026 | 4.158B |
| August 31, 2026 | 4.213B |
| August 28, 2026 | 4.153B |
| August 27, 2026 | 4.322B |
| August 26, 2026 | 4.367B |
| August 25, 2026 | 4.364B |
| August 24, 2026 | 4.306B |
| August 21, 2026 | 4.324B |
| August 20, 2026 | 4.304B |
| August 19, 2026 | 4.437B |
| August 18, 2026 | 4.307B |
| August 17, 2026 | 4.332B |
| August 14, 2026 | 4.258B |
| August 13, 2026 | 4.301B |
| August 12, 2026 | 4.336B |
| August 11, 2026 | 4.425B |
| August 10, 2026 | 4.390B |
| Date | Value |
|---|---|
| August 07, 2026 | 4.349B |
| August 06, 2026 | 4.288B |
| August 05, 2026 | 4.336B |
| August 04, 2026 | 4.302B |
| August 03, 2026 | 4.182B |
| July 31, 2026 | 4.172B |
| July 30, 2026 | 4.263B |
| July 29, 2026 | 4.158B |
| July 28, 2026 | 4.291B |
| July 27, 2026 | 4.246B |
| July 24, 2026 | 4.038B |
| July 23, 2026 | 3.947B |
| July 22, 2026 | 3.834B |
| July 21, 2026 | 3.937B |
| July 20, 2026 | 3.874B |
| July 17, 2026 | 3.922B |
| July 16, 2026 | 3.753B |
| July 15, 2026 | 3.963B |
| July 14, 2026 | 3.928B |
| July 13, 2026 | 3.905B |
| July 10, 2026 | 3.869B |
| July 09, 2026 | 4.009B |
| July 08, 2026 | 3.937B |
| July 07, 2026 | 3.937B |
| July 06, 2026 | 3.773B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.210B |
| Neurocrine Biosciences, Inc. | 15.97B |
| Recursion Pharmaceuticals, Inc. | 1.821B |
| Agenus, Inc. | 303.85M |
| Amgen, Inc. | 206.24B |
Market Cap Related Metrics
| Price to Book Value | 4.370 |
| Price | 18.52 |
| Earnings Yield | -17.99% |